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ABOUT I0 years ago, we started an
investigation to try to determine whether
subjects who had been thymectomized for
myasthenia gravis were at an increased
risk of extrathymic malignancy. The in-
vestigation was prompted by interest in
the concept of "immunological surveil-
lance" and by experimental evidence sug-
gesting the likely importance of the thy-
mus in any natural immunological de-
fence mechanisms against cancer. A pre-
liminary report concerned the findings in
383 British patients who underwent thy-
mectomy during the years 1942-64 and
who had been successfully followed to the
end of 1967 (Vessey & Doll, 1972). Five
of these patients had died from extrathy-
mic cancer while 5-5 would have been
expected to have done so from the national
experience. We report here our findings
after an additional 5 years offollow-up.
The total study population consists of
419 patients who underwent thymectomy
for myasthenia gravis at the National
Hospital for Nervous Diseases, New End
Hospital, St Bartholomew's Hospital or
the London Hospital between I January
1942 and 31 December 1964. The means
of identifying the patients is described in
detail in our earlier report. Every effort
has been made to follow these patients to
31 December 1972 and to obtain death
certificates for the deceased. Special en-
quiries have been made aboutpatients cer-
tified as dying from an extrathymic
tumour and information has also been
sought on the occurrence of non-fatal
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tumours, by searching case records and
writing to family doctors.
Thirty-six of the 419 patients were
foreign nationals who came to London
specially for thymectomy. These subjects
are not considered further, but it should
be noted that 34 (94%) have been success-
fully followed to 31 December 1972. None
ofthese 34 (ofwhom II have died) has, to
our knowledge, developed an extrathymic
tumour.
Of the remaining 383 patients, all but
2 (both of whom emigrated to the United
States) have been followed to 31 Decem-
ber 1972 (a success rate of 99-5%). The
characteristics of these patients are given
in detail in our earlier report: about two-
thirds were female, about one-sixth had a
thymoma, and about one half were aged
20-39 at the time ofoperation.
The number ofyears that these patients
have been at risk ofdying have been com-
puted separately for those with and with-
out thymoma, for each sex and 5-year age
group, for each 5-year period after thy-
mectomy (0-4, 5-9, etc.) and for each 5-
year calendarperiod ofobservation (1940-
44. 1945-49, etc.). These numbers have
been multiplied by the corresponding
death rates for England and Wales, and
an estimate has thus been obtained of the
numbers ofdeaths that would be expected
if the patients had suffered the same
mortality as the general population.
Table I shows the observed and expect-
ed numbers of deaths among the 381
patients followed to 31 December, 1972.M. P. VESSEY, R. DOLL, B. NORMAN-SMITH, I. D. HILL
TABLE L.-Observed and expected numbers of deaths by cause according to sex and thyrnic
pathology
Cause of death
Thymic
pathology
No thymoma
Thymoma
No thymoma
Thymoma
Total
Total
patients
85
23
231
42
Myasthenia
or thymoma
Obs Exp*
15
15
49
27 -
Extrathymic
tumours
Obs Exp
2 3-08
2 0 59
7 4-28
0 0-83
Respiratory
disease
(excl. ca)
Obs Exp
2 1-67
0 0-28
1 0-89
1 0-24
Circulatory
disease
Obs Exp
9 4-65
1 0-82
3 2-84
1 0-86
Other
causes
Obs Exp
4 3-32
1 0 53
6 4 07
2 0-87
381 106 11 8-78 4 3-08 14 9-17 13 8-79
* Expected deaths in this column not computed, but close to zero.
TABLE II.-Numbers of deaths from extrathymtic tumours, observed and expected, by age
groups and interval since thymectomy. Patients ofboth sexes with and without thymoma
Interval since thymectomy (years)
I _A ---
-4 5-9
Age ' -&
(years) Obs Exp Obs Exp
-19 0 0-01 0 0-00
20-39 0 0 20 1 0 20
40-59 0 0 82 0 1-02
60+ 0 0-23 0 0-42
Total 0 1-26 1 1-64
10-14
A--
Obs Exp
0 0.00
2 0-14
3 1-09
2 0-63
7 1-86
15-19
Obs Exp
0 0 00
0 0 07
0 1 02
0 0-92
0 2-01
20+
Obs Exp
0 0.00
0 0-02
0 0-92
3 1-07
3 2-01
Total
Obs Exp
0 0-01
3 0-63
3 4-87
5 3-27
11 8-78
In addition to the anticipated excess mor-
tality from myasthenia gravis and thy-
moma, there is a small (and statistically
significant) increase in mortality among
the thymectomized patients from all other
causes, including extrathymic tumours (42
deaths observed, 29 8 expected, P=0.034).
Deaths due to extrathymic tumours alone
are slightly, but not statistically signifi-
cantly, increased (11 observed, 8 8 expect-
ed, P=0'5).
Table II shows how the 11 deaths from
extrathymic tumours are distributed with
respect to age and interval since thymec-
tomy. The most notable feature is the
occurrence of 7 deaths 10-14 years after
thymectomy in comparison with only 19
expected (P=0.003). There is, however,
no suggestion of an overall relationship
between interval since operation and
cancer mortality and, while it seems un-
reasonable to ascribe such an unlikely
observation to chance, we have at present
no alternative suggestion to offer.
Information concerning the nature of
the 11 fatal tumours is given in Table III,
which also provides details of 11 non-fatal
tumours diagnosed during the follow-up
period. These data do not suggest that any
particular type oftumour tends to develop
after thymectomy. Nor does the number
of as yet non-fatal tumours diagnosed sug-
gest that the incidence of cancer (as
opposed to the mortality from it) is likely
to be raised.
In our earlier report, we concluded that
our study provided no evidence that adult
thymectomy is followed by an increased
risk of neoplastic disease. This conclusion
is reinforced by the additional data now
available.
Papatestas et al. (1977) have presented
an analysis of the records of 2000 patients
with myasthenia gravis registered at the
Mount Sinai Hospital (New York) or at
New End Hospital (London). Of these
patients, 789 had undergone thymectomy.
The risk of developing cancer was calcu-
Sex
M
M
F
F
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TABLE III.-Details of extrathymic tu-
mours.
Interval
Age since
Case Thy- at thymec- Nature of
no.* Sex moma death tomy tumour
Fatal
426 (1) F 29 9 Hodgkin's
disease
154 (2) F - 34 13 Astrocytoma
489 (3) F 37 11 Osteogenic
sarcoma
167 (4) F 45 11 Ca. breast
357 (5) F -- 53 14 Ca. abdominal
wall
009 M - 60 13 Ca. stomach
333 M + 69 14 Ca. prostate
152 (7) M 47 13 Carcinomatosis
(10 site
unknown)
386 M 73 21 Pelvic tumour
(10 site
unknown)
336 F - 62 27 Ca. breast
480 (8) F - 63 26 Chronic
lymphatic
leukaemia
Age
at
diag-
nosis
Non-fatal
109 (6) M V 43 11 Ca. breast
331 (9) F - 55 13 Bronchial
adenoma
104 (10) F 57 16 Pituitary
adenoma
137 F 67 20 Epithelioma
(skin)
443 F - 57 13 Ca. cervix
032 F 62 10 Ca. breast
142 F 40 10 Ca. cervix
367 F 53 21 Ca. breast
404 F 60 26 Rodent ulcer
433 F -- 64 15 Ca. vagina
486 F -- 63 22 Ca. recto-
sigmoid
* Numbers in parentheses relate to reference
numbers in our 1972 paper.
lated separately in the period of observa-
tion after the onset ofmyastheniabutprior
to thymectomy and in the period ofobser-
vation following thymectomy. Connecticut
Cancer Registry data were used to calcu-
late expected numbers of cancers in the
two periods. Clearly this approach has a
number of major shortcomings (not the
least of which is the fact that the patients
who underwent thymectomy could not, of
necessity, have suffered a fatal cancer
prior to the operation) but Papatestas and
his colleagues none the less came to the
conclusion that myasthenia gravis itself
is associated with an increased cancer risk
which is reduced by thymectomy. Since
all the patients in our study had had a
thymectomy, we clearly cannot confirm or
refute this suggestion. It should also be
noted that there must be some overlap
between our data and those of Papatestas
et at., but the way in which they present
their results prevents any direct com-
parisons.
Six years ago, the concept of immuno-
logical surveillance against neoplasia was
almost scientific dogma, but many workers
in the field are now expressing doubts
about its reality (Moller & Moller, 1976).
Our findings, perhaps, add a little weight
to the latter view.
We should like to thank the physicians and
surgeons at the National Hospital, New End
Hospital, St Bartholomew's Hospital and the Lon-
don Hospital for permission to study patients under
their care.
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